908 Devices Inc. (MASS) Stock Price & Analysis
908 Devices Inc. (MASS) rose 0.10% to USD 10.05 as of September 8, 2026 at 06:54 UTC, according to Nexqual real-time market data.
MASS last closed at USD 10.04; the session ranged USD 9.87–10.12 on volume of 201,068 shares. Market capitalization is $415.40M, with a 52-week range of USD 5.03–11.25 (NGM). Source: Nexqual, September 8, 2026 at 06:54 UTC.
Key Statistics (as of September 8, 2026 at 06:54 UTC)
| Price | USD 10.05 |
|---|---|
| Change | ▲ 0.10% (up) |
| Previous Close | USD 10.04 |
| Open | USD 10.02 |
| Day Range | USD 9.87 – 10.12 |
| 52-Week Range | USD 5.03 – 11.25 |
| Volume | 201,068 shares |
| Market Cap | $415.40M |
| Exchange | NGM |
Technical Analysis (MASS)
Nexqual's technical model rates MASS "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:54 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 55.69 (neutral) |
| vs SMA50 | Above (USD 8.91) |
| MACD | 0.45 (positive) |
Analyst Ratings (MASS)
Wall Street analysts rate MASS "None" based on 3 analysts, with a mean price target of USD 13 (range USD 12–14), per Nexqual as of September 8, 2026 at 06:54 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 13 |
| High Target | USD 14 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 5 / 0 / 0 |
Earnings (MASS)
| Next Earnings Date | 2026-11-10 |
|---|---|
| EPS Estimate | USD -0.1 |
| Revenue Estimate | $18.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.06 vs est -0.14 ▲ beat |
| 2026-03-31 | USD -0.07 vs est -0.14 ▲ beat |
| 2025-12-31 | USD 0.02 vs est -0.06 ▲ beat |
| 2025-09-30 | USD -0.04 vs est -0.12 ▲ beat |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
Financials & Fundamentals (MASS)
| Total Revenue | $60.84M |
|---|---|
| Revenue Growth (YoY) | +23.30% |
| Gross Margin | +52.65% |
| Operating Margin | -39.61% |
| Profit Margin | -56.96% |
| ROE | -24.95% |
| Debt / Equity | 3.39 |
| Current Ratio | 2.67 |
| Total Cash | $101.53M |
| Total Debt | $4.30M |
| Free Cash Flow | $18.68M |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
Financial Health Score (MASS)
Nexqual rates 908 Devices Inc.'s overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 06:54 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 53%, operating -40% |
| Balance Sheet | Strong — $102M cash vs $4M debt, net cash position |
| Cash Flow | Strong — FCF $19M, 33% margin |
| Efficiency | Critical — ROE -25%, ROA -6.8% |
Ownership (MASS)
| Insider Ownership | +7.46% |
|---|---|
| Institutional Ownership | +83.82% |
| Shares Outstanding | 41.33M |
| Float | 28.06M |
| Short % of Float | +13.15% |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
Leadership (MASS)
908 Devices Inc. is led by Kevin J. Knopp (age 52), Co-Founder, CEO, President & Director, per Nexqual as of September 8, 2026 at 06:54 UTC.
| Co-Founder, CEO, President & Director | Kevin J. Knopp (age 52) |
|---|---|
| Co-Founder, Board Advisor & Director | Christopher David Brown (age 50) |
| CFO & Treasurer | Joseph H. Griffith (age 50) |
| Senior Vice President of Sales and Product Marketing | John Kenneweg (age 52) |
| Senior Vice President of Products and Production | Kevin McCallion (age 59) |
Major Backers & Investors (MASS)
Notable institutional backers of 908 Devices Inc. include First Light Asset Management, LLC, AWM Investment Company, Inc., ARK Invest, according to Nexqual as of September 8, 2026 at 06:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Light Asset Management, LLC | 15.2% |
| AWM Investment Company, Inc. | 11.81% |
| ARK Invest | 9.52% |
| Needham Investment Management, L.L.C. | 4.4% |
| First Eagle Investment Management, LLC | 4% |
| Needham Funds Inc-Needham Aggressive Growth Fund | 3.99% |
| Granahan Investment Management LLC | 1.67% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.16% |
| Vanguard Group | 6.17% |
| Geode Capital | 1.84% |
Source: Nexqual, September 8, 2026 at 06:54 UTC.
From 908 Devices Inc.'s Latest SEC 10-K Filing (filed 2026-03-09)
Key Strengths & Strategy (as disclosed to the SEC)
- 908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.
- It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SEER | Seer, Inc. | USD 1.95 | ▼ 1.52% |
| PSNL | Personalis, Inc. | USD 17.2 | ▲ 2.81% |
| CDXS | Codexis, Inc. | USD 1.46 | ▼ 1.35% |
| CSTL | Castle Biosciences, Inc. | USD 32.91 | ▼ 1.53% |
| VCYT | Veracyte, Inc. | USD 42.53 | ▼ 5.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:54 UTC. This page is informational and not investment advice.